Insider buying last 90 days
No open-market insider purchases were filed for XRAY in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every XRAY insider filing, plotted on the chart in Gekko.Open XRAY in Gekko
NASDAQ: XRAY
DENTSPLY SIRONA (XRAY) Stock Analysis & Forecast
Oct 12 close
$8.53−0.30 (−3.4%)
Gekko Brief
AI summaryOct 12 closeThis week's news centers on commercial expansion and balance-sheet management rather than core results. Dentsply Sirona expanded its U.S. distribution reach through an agreement with Midwest Dental, broadening access to its digital dentistry portfolio effective November 1, 2026. Separately, the company secured covenant relief through amendments to its revolving credit facility and related note agreements, consented to by lenders on October 8, 2026. Piper Sandler maintained a Neutral rating while lowering its price target from $14 to $12, and other commentary flagged the stock trading toward its lowest close since March 2000.
XRAY closed at $8.53, down 3.4%, sitting below both its 50-day average of $10.55 and its 200-day average of $11.53, with the 50-day below the 200-day. The stock's one-month return stands at -18.5% and its one-year return at -30.2%, within a 52-week range of $8.38 to $14.76. The GekkoIndex reads 67.1, placing XRAY in the Accumulation zone. Price sits 27.4% below Gekko Fair Value of $11.75.
Earnings are scheduled for 5 November 2026, 23 days out and inside a typical 20-trading-day hold; the last report produced a -12% reaction despite an EPS beat of $0.52 versus $0.36 estimated. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality over the past 5 years shows the next 20 trading days averaging -4.5%, with 0 of those years positive. Analyst consensus across 12 firms shows 2 buy, 9 hold, and 1 sell ratings, with a consensus target of $13.4.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
DENTSPLY SIRONA price vs fair value
Close $8.53200-day averageGekko Fair Value $11.75
DENTSPLY SIRONA quick facts
- Market cap
- $1.71B
- P/E ratio
- —
- Forward P/E
- 6.3
- EPS, TTM
- −$2.73
- Revenue, TTM
- $3.64B
- Profit margin
- -15%
- Dividend yield
- 3.75%
- Beta
- 0.88
- Volume
- 4.69M avg 5.48M
- 1-year return
- −30.2%
- Typical daily move
- ±3.6%
- Typical 20-day move
- ±6.9%
- 50-day average
- $10.55
- 200-day average
- $11.53
- Next earnings
- Nov 5
- Shares outstanding
- 199.4M
DENTSPLY SIRONA swing-trade checklist
DENTSPLY SIRONA scores 2 supportive, 0 mixed and 3 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive0 mixed3 headwinds
- Trendheadwind
Below 50 and 200-day
Close $8.53 is below the 50-day ($10.55) and 200-day ($11.53) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
67.1, Accumulation
Reading 67.1 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
27.4% below
Price is 27.4% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 24 days
Reports on Nov 5, 2026, 24 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−4.5% on average
From this point in the calendar, the next 20 trading days averaged −4.5% over 5 years, rising in 0 of them.
See seasonality
A description of current data, not a recommendation. How this page works
DENTSPLY SIRONA stock chart and price history
DENTSPLY SIRONA closed at $8.53 on Oct 12, 2026, −30.2% over the past year, inside a 52-week range of $8.38 to $14.76.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −18.5%
- 3 months
- −32.8%
- 6 months
- −29.0%
- 1 year
- −30.2%
The full XRAY chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open XRAY in Gekko
Follow DENTSPLY SIRONA through every session
Put XRAY on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track XRAY in GekkoFree for 7 days. No credit card required.
About DENTSPLY SIRONA
DENTSPLY SIRONA designs, manufactures, and sells dental equipment and supplies, alongside cloud-enabled technology and consumable health products used in urology and bowel care. Dental professionals know the company for tools such as intraoral scanners, imaging equipment, treatment centers, and CEREC chairside ceramic restoration systems, as well as clear aligners, implants, and related digital planning software.
The company organizes its work into four segments. Connected Technology Solutions covers imaging equipment, handpieces, scanners, printers, and chairside restoration tools. Essential Dental Solutions supplies endodontic instruments, restorative materials, anesthetics, and related clinical products. Orthodontic and Implant Solutions includes aligners, implants, dentures, bone regeneration materials, and digital treatment planning tools. Wellspect Healthcare produces catheters and irrigation systems for patients with urinary retention or chronic constipation.
The company traces its origins to 1877 and took its current name in February 2016, after previously operating as DENTSPLY International Inc. It is headquartered in Charlotte, North Carolina, and its shares are listed on the NASDAQ under the ticker XRAY.
- Listed
- NASDAQ
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- dentsplysirona.com
DENTSPLY SIRONA GekkoIndex: the smart money zone
DENTSPLY SIRONA’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 67.1, in the Accumulation zone, down 2.3 points over five sessions.
67.1Accumulation
Down 2.3 points over five sessions.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 90 | +0.3% | +1.1% | ||
| Accumulation (current zone) | 317 | −1.4% | −3.8% | ||
| Neutral | 265 | −0.5% | −3.9% | ||
| Distribution | 9 | Too few readings yet | |||
| Selling | 1 | Too few readings yet | |||
Average XRAY share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the XRAY price, zone by zone.Track XRAY in Gekko
Is DENTSPLY SIRONA stock overvalued? Gekko Fair Value
DENTSPLY SIRONA trades 27.4% below Gekko Fair Value of $11.75, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what DENTSPLY SIRONA shares are worth, recalculated every trading day.
$11.75
Gekko Fair Value, Oct 10, 2026
27.4% Undervalued
At the end of Aug 2026 the price was 15.1% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open XRAY in Gekko
DENTSPLY SIRONA insider and Congress trading
No open-market insider purchases were filed for DENTSPLY SIRONA, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in XRAY were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for XRAY, plotted on the chart in Gekko.Open XRAY in Gekko
Buybacks
DENTSPLY SIRONA has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $12.00M
- As a share of market cap
- 0.70%
From company filings.
Hedge funds and billionaires quarter ended Dec 31
0of the funds Gekko tracks hold XRAY.
0added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko
DENTSPLY SIRONA earnings: next date and track record
DENTSPLY SIRONA reports on Nov 5, 2026 (24 days away), and beat the EPS estimate in 4 of its last 8 reports.
Next earnings report
Nov 5, 2026
24 days away
- EPS estimate
- $0.31
- Revenue estimate
- $862.8M
4 of 8reports beat the EPS estimate
±12.1%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 6, 2026 AI summary
- What they said
- Dentsply Sirona reported Q2 2026 revenue of $898 million, down 4.1% as reported and 6.3% on constant currency basis. Adjusted EPS was flat at $0.52, with $44 million in tariff refunds providing a $0.17/share benefit. Operating cash flow improved to $99 million from $48 million prior year. The company repurchased 1.3 million shares below $10/share, first buyback since Q3 2024. Net debt to EBITDA stood at 3.2x.
- Guidance
- Management is executing a return-to-growth action plan with investments in sales, marketing, and R&D. Debt reduction remains a priority. Full guidance details were not captured in the provided transcript excerpt.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $0.52 est $0.36 | $898.0M est $889.9M | −12.0% |
| May 5, 2026 | $0.27 est $0.27 | $880.0M est $841.8M | −0.5% |
| Feb 26, 2026 | $0.27 est $0.28 | $961.0M est $926.2M | +14.7% |
| Nov 6, 2025 | $0.37 est $0.45 | $904.0M est $927.1M | −11.4% |
| Aug 7, 2025 | $0.52 est $0.50 | $936.0M est $904.6M | −5.3% |
| May 8, 2025 | $0.43 est $0.30 | $879.0M est $920.2M | +15.6% |
| Feb 27, 2025 | $0.26 est $0.43 | $905.0M est $901.3M | −12.0% |
| Nov 7, 2024 | $0.50 est $0.47 | $951.0M est $937.0M | −25.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
DENTSPLY SIRONA stock forecast and analyst price targets
Analysts’ average 12-month price target for DENTSPLY SIRONA is $13.40, +57.1% from the last close, from 12 firms rating the stock in the last 90 days.
$13.40consensus 12-month target, +57.1% from the last close
Now $8.53Avg $13.40
Low $10High $17
Each firm’s latest rating in the last 90 days: 12 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 12 | Bank of America Securities | $17 | +99.3% |
| Oct 9 | Piper Sandler | $12 | +40.7% |
| Oct 7 | Bank of America Securities | $17 | +99.3% |
| Sep 17 | J.P. Morgan | $12 | +40.7% |
| Sep 16 | BMO Capital | $10 | +17.2% |
−3.8%average 20-day move after past Accumulation readings
−4.5%average move over the next 20 trading days in the last 5 years
±3.6%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
DENTSPLY SIRONA seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, DENTSPLY SIRONA averaged −4.5% across the last 5 years, rising in 0 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.6% | 3 of 5 |
| Next 10 trading days | +3.0% | 4 of 5 |
| Next 15 trading days | +1.5% | 3 of 5 |
| Next 20 trading days | −4.5% | 0 of 5 |
| Next 30 trading days | −7.8% | 1 of 5 |
For scale, XRAY’s typical 20-trading-day move in either direction is about 6.9%.
DENTSPLY SIRONA market cap and key statistics
DENTSPLY SIRONA’s market cap is $1.71B and revenue of $3.64B over the last twelve months.
Valuation
- Market cap
- $1.71B
- Forward P/E
- 6.3
- EPS, TTM
- −$2.73
- Gekko Fair Value
- $11.75
Trading
- Volume
- 4.69M
- Avg volume, 20 days
- 5.48M
- 52-week high
- $14.76
- 52-week low
- $8.38
- Shares outstanding
- 199.4M
Financials
- Revenue, TTM
- $3.64B
- Profit margin
- -15%
- Return on equity
- -33%
- Quarterly earnings growth, YoY
- +15.2%
Risk and income
- Beta
- 0.88
- Typical daily move
- ±3.6%
- Typical 20-day move
- ±6.9%
- Dividend yield
- 3.75%
DENTSPLY SIRONA stock news this week
Coverage of DENTSPLY SIRONA this week reads negative: 4 positive, 1 neutral and 5 negative headlines.
- Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest DealZacks Investment Research, Oct 12
- Dentsply Sirona (NASDAQ: XRAY) secures covenant relief in debt amendmentsDefense World, Oct 12
- Piper Sandler maintains Neutral rating on Dentsply Sirona, $12 price targetTradingView, Oct 9
- Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q2 Earnings?TradingView, Oct 9
- DENTSPLY SIRONA on Track for Lowest Close Since March 2000 -- Data TalkMoomoo, Oct 9
- Dentsply Sirona expands distribution deal with Midwest Dental By Investing.comInvesting.com Nigeria, Oct 7
DENTSPLY SIRONA peers
DENTSPLY SIRONA’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Neutral | 18.2% above |
| ABTAbbott Laboratories | Neutral | 14.7% below |
| DHRDanaher | Neutral | 4.5% above |
| ISRGIntuitive Surgical | Neutral | 18.8% above |
| MDTMedtronic | Neutral | 22.9% below |
| SYKStryker | Accumulation | 12.6% below |
A peer links to its own page where one exists.
DENTSPLY SIRONA stock FAQ
What is DENTSPLY SIRONA’s market cap?
DENTSPLY SIRONA’s market cap is $1.71B at the Oct 12, 2026 close of $8.53, with 199.4M shares outstanding.
What is the DENTSPLY SIRONA stock forecast?
The consensus analyst 12-month price target for DENTSPLY SIRONA is $13.40, +57.1% from the last close. Of the 12 firms that rated the stock in the last 90 days, 2 rate it a buy, 9 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
Is DENTSPLY SIRONA stock overvalued or undervalued?
On Gekko’s estimate DENTSPLY SIRONA is undervalued: the Oct 12, 2026 close of $8.53 is 27.4% below Gekko Fair Value of $11.75. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does DENTSPLY SIRONA report earnings next?
DENTSPLY SIRONA is expected to report on Nov 5, 2026 (24 days away). Analysts expect earnings of $0.31 per share on revenue of $862.8M. DENTSPLY SIRONA beat the earnings estimate in 4 of its last 8 reports, moving 12.1% on average across the report.
What is DENTSPLY SIRONA’s 52-week high and low?
DENTSPLY SIRONA’s 52-week high is $14.76 and its 52-week low is $8.38; it closed at $8.53 on Oct 12, 2026, −30.2% over the past year. Over the last five years the shares peaked at $59.46 on Nov 2, 2021.
Is DENTSPLY SIRONA stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and fair value) and 3 as headwinds (trend, earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See DENTSPLY SIRONA the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.